These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7333940)

  • 1. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
    Granoff AB
    J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia.
    Richards GE; Grumbach MM; Kaplan SL; Conte FA
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1208-15. PubMed ID: 233693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA; Urban MD; Gutai JP; Migeon CJ
    Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
    Frisch H; Parth K; Schober E; Swoboda W
    Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW; Loriaux DL
    Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
    Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.
    Hughes IA; Winter JS
    J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
    Solish SB; Goldsmith MA; Voutilainen R; Miller WL
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1148-52. PubMed ID: 2555382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian steroidogenesis in an adrenalectomized girl with 21-hydroxylase deficiency.
    Zachmann M; Manella B; Kempken B; Knorr-Muerset G; Atares M; Prader A
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):575-82. PubMed ID: 6094047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG; Sippell WG
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
    McKenna TJ; Jennings AS; Liddle GW; Burr IM
    J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of virilizing adrenal hyperplasia in adolescents. Use and side-effects of dexamethasone].
    Job JC; Munck A; Chaussain JL; Canlorbe P
    Arch Fr Pediatr; 1985 Nov; 42(9):765-9. PubMed ID: 4083978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia.
    Peterson RE; Imperato-McGinley J; Gautier T; Shackleton C
    N Engl J Med; 1985 Nov; 313(19):1182-91. PubMed ID: 2932643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of plasma renin activity and plasma aldosterone level during dexamethasone suppression test in non-salt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kinoshita K; Ishida H; Minowada S; Niijima T
    Endocrinol Jpn; 1980 Dec; 27(6):747-51. PubMed ID: 7021135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identical male twins with congenital adrenal hyperplasia. Comparison of growth, serum and urinary steroids.
    Connors MH; Sheikholislam BM
    West J Med; 1976 Apr; 124(4):335-8. PubMed ID: 1266219
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.
    Winterer J; Chrousos GP; Loriaux DL; Cutler GB
    J Pediatr; 1985 Jan; 106(1):137-42. PubMed ID: 3871229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Holmes-Walker DJ; Conway GS; Honour JW; Rumsby G; Jacobs HS
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):291-6. PubMed ID: 7586597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.